Epistaxis in hospitalized patients with COVID-19

Author:

Dell’Era Valeria1ORCID,Dosdegani Riccardo2,Valletti Paolo Aluffi1,Garzaro Massimiliano1

Affiliation:

1. ENT Division, University of Eastern Piedmont, Novara, Italy

2. ENT Division, Sant’Andrea Hospital, Vercelli, Italy

Abstract

Spontaneous epistaxis in patients with COVID-19 can represent a clinical challenge with respect to both the risk of contamination and the treatment options. We herein present the data of 30 patients with COVID-19 who developed spontaneous epistaxis while hospitalized at Eastern Piedmont Hospital during March and April 2020. All patients received low-molecular-weight heparin during their hospital stay and required supplementary oxygen therapy either by a nasal cannula or continuous positive airway pressure. Both conditions can represent risk factors for developing epistaxis. Prevention of crust formation in patients with rhinitis using a nasal lubricant should be recommended. If any treatment is required, appropriate self-protection is mandatory.

Publisher

SAGE Publications

Subject

Biochemistry (medical),Cell Biology,Biochemistry,General Medicine

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Bleeding Complications in COVID-19 Critically Ill ARDS Patients Receiving VV-ECMO Therapy;Journal of Clinical Medicine;2023-10-09

2. Impact of ENT complications on COVID-19 patients in a tertiary care center, Coimbatore: a retrospective cross-sectional study;The Egyptian Journal of Otolaryngology;2023-06-12

3. Otolaryngologic Presentations to Emergency Departments During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis;Annals of Otology, Rhinology & Laryngology;2023-04-04

4. Republication de : Hide and seek epistaxis after COVID-19 infection;Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale;2022-09

5. Hide and seek epistaxis after COVID-19 infection;European Annals of Otorhinolaryngology, Head and Neck Diseases;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3